Penn Mutual Asset Management’s Novartis NVS Stock Holding History

Penn Mutual Asset Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,120	Closed	-$315K	–	84
2023 Q4	$315K	Sell	3,120 -1,000	-24%	-$96.5K	0.24%	59
2023 Q3	$420K	Hold	4,120	–	–	0.39%	50
2023 Q2	$416K	Hold	4,120	–	–	0.37%	51
2023 Q1	$379K	Hold	4,120	–	–	0.36%	50
2022 Q4	$374K	Hold	4,120	–	–	0.42%	47
2022 Q3	$313K	Buy	+4,120	New	+$342K	0.41%	54

Other funds holding NVS

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Penn Mutual Asset Management's NVS Position: Q1 2024 in Review

Penn Mutual Asset Management sold out of Novartis (NVS) in Q1 2024, closing a stake of 3,120 shares — an estimated $315K sold.

Penn Mutual Asset Management first reported a position in NVS in Q3 2022 and held it in 6 quarters. The position peaked at $420K in Q3 2023. 1,253 funds tracked by Wall St. Rank hold NVS as of Q1 2024.

Penn Mutual Asset Management reported no remaining Novartis position as of Q1 2024 after selling out during the quarter.
Penn Mutual Asset Management sold 3,120 Novartis shares in Q1 2024, an estimated $315K.
Penn Mutual Asset Management first reported a position in Novartis in Q3 2022 and held it in 6 quarters.
Penn Mutual Asset Management's Novartis position peaked at $420K in Q3 2023.
1,253 funds tracked by Wall St. Rank held Novartis as of Q1 2024.

Based on Penn Mutual Asset Management's 13F filing for Q1 2024, filed 15 May 2024.